CRP and inflammatory bowel disease: In spite of the known anti-inflammatory properties of omega-3 PUFAs, attributed to their ability to reduce the production of cytokines [32,33] and C-reactive protein (CRP) [34], the available data provided less convincing evidence to support the use of omega-3 PUFAs in the prevention or treatment of IBD.